T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 26.12 CNY -2.28%
Market Cap: 2.1B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

Tongling Jieya Biologic Technology Co Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tongling Jieya Biologic Technology Co Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
T
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Net Change in Cash
-ÂĄ346m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Net Change in Cash
-ÂĄ2.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Net Change in Cash
-ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
-101%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Net Change in Cash
-ÂĄ366.8m
CAGR 3-Years
N/A
CAGR 5-Years
-99%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Net Change in Cash
ÂĄ365.2m
CAGR 3-Years
65%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Net Change in Cash
ÂĄ1.2B
CAGR 3-Years
58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tongling Jieya Biologic Technology Co Ltd
Glance View

Market Cap
2.1B CNY
Industry
Consumer products

Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipes. The company is headquartered in Tongling, Anhui and currently employs 798 full-time employees. The company went IPO on 2021-12-03. The firm's main businesses are the research and development, production and sales of sanitary products. The firm's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The firm is also engaged in the production of facial masks.

Intrinsic Value
22.95 CNY
Overvaluation 12%
Intrinsic Value
Price
T

See Also

What is Tongling Jieya Biologic Technology Co Ltd's Net Change in Cash?
Net Change in Cash
-346m CNY

Based on the financial report for Dec 31, 2023, Tongling Jieya Biologic Technology Co Ltd's Net Change in Cash amounts to -346m CNY.

What is Tongling Jieya Biologic Technology Co Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
1%

Over the last year, the Net Change in Cash growth was 1%.

Back to Top